Literature DB >> 25178633

Policy: EU data protection regulation--harming cancer research.

David J Kerr1.   

Abstract

The cancer community is deeply concerned about the unintended consequences of the current wording of the European Union (EU) draft Regulation on Data Protection, which may challenge the survival of retrospective clinical research, biobanking, and population-based cancer registries in the EU. This directive could negatively affect Europe's competitiveness in cancer research.

Entities:  

Mesh：

Year:  2014        PMID： 25178633     DOI： 10.1038/nrclinonc.2014.148

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


  9 in total

1.  Validation study of a quantitative multigene reverse transcriptase-polymerase chain reaction assay for assessment of recurrence risk in patients with stage II colon cancer.

Authors:  Richard G Gray; Philip Quirke; Kelly Handley; Margarita Lopatin; Laura Magill; Frederick L Baehner; Claire Beaumont; Kim M Clark-Langone; Carl N Yoshizawa; Mark Lee; Drew Watson; Steven Shak; David J Kerr
Journal:  J Clin Oncol       Date:  2011-11-07       Impact factor: 44.544

2.  Gene expression signature to improve prognosis prediction of stage II and III colorectal cancer.

Authors:  Ramon Salazar; Paul Roepman; Gabriel Capella; Victor Moreno; Iris Simon; Christa Dreezen; Adriana Lopez-Doriga; Cristina Santos; Corrie Marijnen; Johan Westerga; Sjoerd Bruin; David Kerr; Peter Kuppen; Cornelis van de Velde; Hans Morreau; Loes Van Velthuysen; Annuska M Glas; Laura J Van't Veer; Rob Tollenaar
Journal:  J Clin Oncol       Date:  2010-11-22       Impact factor: 44.544

3.  Breast cancer: Investment biobanking--increased returns from tissue samples.

Authors:  Valerie Speirs; Adrienne Morgan
Journal:  Nat Rev Clin Oncol       Date:  2013-02-05       Impact factor: 66.675

4.  Risks of the new EU Data Protection Regulation: an ESMO position paper endorsed by the European oncology community.

Authors:  P G Casali
Journal:  Ann Oncol       Date:  2014-08       Impact factor: 32.976

Review 5.  'Toxgnostics': an unmet need in cancer medicine.

Authors:  David Church; Rachel Kerr; Enric Domingo; Dan Rosmarin; Claire Palles; Kevin Maskell; Ian Tomlinson; David Kerr
Journal:  Nat Rev Cancer       Date:  2014-05-15       Impact factor: 60.716

6.  Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study.

Authors:  Roberta De Angelis; Milena Sant; Michel P Coleman; Silvia Francisci; Paolo Baili; Daniela Pierannunzio; Annalisa Trama; Otto Visser; Hermann Brenner; Eva Ardanaz; Magdalena Bielska-Lasota; Gerda Engholm; Alice Nennecke; Sabine Siesling; Franco Berrino; Riccardo Capocaccia
Journal:  Lancet Oncol       Date:  2013-12-05       Impact factor: 41.316

7.  Value of mismatch repair, KRAS, and BRAF mutations in predicting recurrence and benefits from chemotherapy in colorectal cancer.

Authors:  Gordon Hutchins; Katie Southward; Kelly Handley; Laura Magill; Claire Beaumont; Jens Stahlschmidt; Susan Richman; Philip Chambers; Matthew Seymour; David Kerr; Richard Gray; Philip Quirke
Journal:  J Clin Oncol       Date:  2011-03-07       Impact factor: 44.544

Review 8.  Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis.

Authors:  Dan Rosmarin; Claire Palles; David Church; Enric Domingo; Angela Jones; Elaine Johnstone; Haitao Wang; Sharon Love; Patrick Julier; Claire Scudder; George Nicholson; Anna Gonzalez-Neira; Miguel Martin; Daniel Sargent; Erin Green; Howard McLeod; Ulrich M Zanger; Matthias Schwab; Michael Braun; Matthew Seymour; Lindsay Thompson; Benjamin Lacas; Valérie Boige; Nuria Ribelles; Shoaib Afzal; Henrik Enghusen; Søren Astrup Jensen; Marie-Christine Etienne-Grimaldi; Gérard Milano; Mia Wadelius; Bengt Glimelius; Hans Garmo; Milena Gusella; Thierry Lecomte; Pierre Laurent-Puig; Eva Martinez-Balibrea; Rohini Sharma; Jesus Garcia-Foncillas; Zdenek Kleibl; Alain Morel; Jean-Pierre Pignon; Rachel Midgley; David Kerr; Ian Tomlinson
Journal:  J Clin Oncol       Date:  2014-03-03       Impact factor: 50.717

9.  Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas.

Authors:  Claire Palles; Jean-Baptiste Cazier; Kimberley M Howarth; Enric Domingo; Angela M Jones; Peter Broderick; Zoe Kemp; Sarah L Spain; Estrella Guarino; Estrella Guarino Almeida; Israel Salguero; Amy Sherborne; Daniel Chubb; Luis G Carvajal-Carmona; Yusanne Ma; Kulvinder Kaur; Sara Dobbins; Ella Barclay; Maggie Gorman; Lynn Martin; Michal B Kovac; Sean Humphray; Anneke Lucassen; Christopher C Holmes; David Bentley; Peter Donnelly; Jenny Taylor; Christos Petridis; Rebecca Roylance; Elinor J Sawyer; David J Kerr; Susan Clark; Jonathan Grimes; Stephen E Kearsey; Huw J W Thomas; Gilean McVean; Richard S Houlston; Ian Tomlinson
Journal:  Nat Genet       Date:  2012-12-23       Impact factor: 38.330
  9 in total
  1 in total

1.  Big Data in medical research and EU data protection law: challenges to the consent or anonymise approach.

Authors:  Menno Mostert; Annelien L Bredenoord; Monique C I H Biesaart; Johannes J M van Delden
Journal:  Eur J Hum Genet       Date:  2015-11-11       Impact factor: 4.246
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.